Chronic granulomatous disease: three cases with different presentations
PDF (Español (España))

Keywords

Abscesses
Adenitis
Chronic Granulomatous Disease
Granulomas
Recurrent Infections
Immunodeficiency
Immunology
Immune System Diseases
Primary Immunodeficiency Diseases

How to Cite

1.
Espinoza D. G, Butte B. K, Palma P. V, Norambuena R. X, Quezada L. A. Chronic granulomatous disease: three cases with different presentations. Andes pediatr [Internet]. 2015 Apr. 6 [cited 2025 Dec. 28];86(2):112-6. Available from: https://andespediatrica.cl/index.php/rchped/article/view/3210

Abstract

Introduction: Chronic granulomatous disease (CGD) is a rare form of primary immunodeficiency disease, characterized by an abnormal susceptibility to bacterial and fungal infections, and it is caused by a deficit in the phagocyte nicotinamide adenine dinucleotide phosphate oxidase complex (NADPH), resulting in    the inability to generate reactive oxygen species that destroy micro organisms. The diagnosis is based on clinical characteristics and analysis of phagocytes, and later confirmed by molecular studies. Its management should consider antimicrobial prophylaxis, a search for infections and aggressive management of these. 

Objective: To describe three cases of CGD emphasizing their forms of presentation and to conduct a review of the condition. 

Case Reports: Three case reports, two of them first cousins, are presented. Molecular diagnosis was reached in one of the cases. Recurrent infections, abscesses, adenitis, granulomas and complications are identified to facilitate the suspected diagnosis of CGD, bearing in mind the importance of early diagnosis and genetic counseling. 

Conclusions: EGC is a rare congenital primary immunodeficiency disorder, mostly with X-linked inheritance, autosomal recessive form, and a specific presentation form. Its diagnosis should be timely to avoid complications. Prophylaxis and aggressive treatment of infections should be performed, as well as genetic counseling.

PDF (Español (España))

Los contenidos publicados en esta revista están protegidos bajo una Licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0). Esto significa que cualquier persona es libre de compartir,  usar y construir a partir de este artículo, incluso con fines comerciales, siempre que se otorgue el crédito apropiado al autor original, se proporcione un enlace a la licencia, se indique el nombre y edición de la Revista.

Esta licencia no impone restricciones adicionales, lo que garantiza la libre circulación y reutilización del conocimiento con respeto y transparencia hacia los derechos de los autores.  (Véase El efecto del acceso abierto).